Synthesis and antimicrobial activity of N1-benzyl or N1-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines

Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs

Rongbao Li, Rachada Sirawaraporn, P. Chitnumsub et al. · Journal of Molecular Biology · 2000 · 205 citations

Life Sciences, Biochemistry, Medicinal Chemistry +14

Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria

Peter Schneider, Stephen Hawser, Khalid Islam · Bioorganic & Medicinal Chemistry Letters · 2003 · 176 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Pharmacophore Mapping of a Series of 2,4-Diamino-5-deazapteridine Inhibitors of <i>Mycobacterium avium</i> Complex Dihydrofolate Reductase

Asim K. Debnath · Journal of Medicinal Chemistry · 2001 · 145 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis

Mervat H. El‐Hamamsy, Anthony W. Smith, Andrew S. Thompson et al. · Bioorganic & Medicinal Chemistry · 2007 · 61 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive Isolates

Hélio S. Sader, Thomas R. Fritsche, Ronald N. Jones · Antimicrobial Agents and Chemotherapy · 2009 · 58 citations · Full text

Life Sciences, Microbiology, Pharmacology +15